Since HA is a major component of the BM niche in MM patients, HA-CD44 interaction could be critical in regulating myeloma CSC functions leading to increased myeloma CSC self-renewal and chemoresistance, as shown in other forms of cancer [59, 60]. The gene discussed is CD44; the disease is Miyoshi myopathy.